Search
Fraunhofer Institute for Cell Therapy and Immunology IZI
Fraunhofer Institute for Cell Therapy and Immunology IZI
Contact
Press / media
Jobs / career
Sitemap
Deutsch
About us
[X]
About us
Institute in numbers
Organization structure
Research networks
Director
Advisory board
Research areas
Departments
[X]
Departments
Leipzig location
Department of GMP Cell and Gene Therapy
Department of Cell and Gene Therapy Development
Cell and Molecular Biology
NK Cell Technologies
In Vivo Models
GMP Development
GMP Biopharmaceuticals
Department of Preclinical Development and Validation
Department of Infection Research and Diagnostics
Vaccine Technologies
Preclinical Validation
Antimicrobial Biotechnology
Experimental Imaging
MicroDiagnostics
Biological Material Analytics
Department of Medical Bioinformatics
DNA Nanodevices
Next-Generation Diagnostics
Bioinformatics
Halle (Saale) location
Department of Drug Design and Target Validation
Drugs and structural biology
Analytics
Pharmacology
Antibody technologies
Rostock location
Department of Extracorporeal Therapy Systems
Würzburg location
Department of Cellular Immunotherapy
Potsdam-Golm location
Central facilities
[X]
Central facilities
RIBOLUTION Biomarker Center
Center for Experimental Medicine
Preclinical models
GLP Test Facility
S3 safety laboratory
Advanced Analytics Technology Platform
Flow cytometry
Chromatography and Mass Spectrometry
Sequencing
Bioinformatics
Microscopy
Binding analytics
CIMD Biomaterial Bank
Press / media
[X]
Press / media
News and press releases
Development of therapeutic antibodies for HERV-associated autoimmune and tumor diseases
Hitchhiker’s Guide to the Cell: Fraunhofer IZI researches to improve imaging methods for organoids
Pathogen of Q fever detected in the feces of ticks
Professor Ulrich Demuth appointed to the German Ethics Council
Patented Fraunhofer IZI technology facilitates specific Dengue virus diagnostics
Astacin Proteases Unit established at Fraunhofer IZI
Prognostic biomarkers for prostate cancer identified
A chemical tailor-made suit for Alzheimer’s drugs
Fraunhofer relies on Automation Technologies in Medical Research
Fraunhofer IZI cooperates with Nomad Bioscience to develop novel anti-bacterial and anti-viral medications
Viromers suitable as carrier systems for gene-based treatment of inflammatory diseases
Fraunhofer IZI presents new technologies and services for the healthcare industry at the Fraunhofer Solution Days
Rapid diagnostic device for trachoma eye infection delivers first promising result
Optimization of novel immune cell therapies
SaxoCell – “living drug” Made in Saxony
Periodontitis: Researchers search for a new active substance
Fraunhofer Prize for Human- and Environment-Centered Technology 2021
Researchers aim at developing a vaccine protecting against urinary tract infection
Simplified method developed for monitoring CAR T-cell therapies using flow cytometry
Anhalt University of Applied Sciences and Fraunhofer IZI open joint research laboratory for natural product-based therapeutics
Researchers want to filter and inactivate airborne pathogens using tissue
Fraunhofer IZI and Nomad Bioscience extend and broaden collaboration
Outstanding bachelor thesis awarded
Fraunhofer opens up prospects in structurally weak regions
New Fraunhofer Center for Digital Diagnostics
Activation of the aryl hydrocarbon receptor (AhR) has an anti-inflammatory effect
Fraunhofer Center MEOS becomes technology hub for cell-based therapeutics in Thuringia
Fraunhofer IZI and BioNTech to collaborate in the future
Preclinical testing of a ATMP for the treatment of knee cartilage damage completed
Fraunhofer develops automated production technologies for mRNA-based drugs
REMEDi4ALL, an ambitious EU-funded research initiative, launches to drive forward the repurposing of medicines in Europe
Roadmap for future production of sufficient product numbers of cell-based cancer drugs
International research team elucidates molecular structure of Meprin alpha
Fraunhofer IZI implements digital Manufacturing Execution System
Hydrogels for tissue engineering
Software development expands portfolio of RIBOLUTION Biomarker Center at Fraunhofer IZI
GLP test facility of the Fraunhofer IZI certified for test category 2 since January 2023
Fraunhofer IZI contributes expertise to Germany's largest collaborative project on mosquito research
Symposium on the farewell of Professor Hans-Ulrich Demuth
Fraunhofer IZI supports the Czech Republic in establishing a research center for the development of novel cell and gene therapies
New strategies in the fight against the widespread disease periodontitis
Preclinical and clinical development of a novel CAR-T cell therapy for the treatment of multiple myeloma and clear cell renal cell carcinoma
Prof. Dr. Dr. Ulrike Köhl elected to the Saxon Academy of Sciences and Humanities in Leipzig
Fraunhofer IZI research project nominated for "HUGO JUNKERS PRIZE for Research and Innovation from Saxony-Anhalt"
Development and evaluation of an MRI-guided focused ultrasound system to improve radiation therapy for cancer
State government of Mecklenburg-Vorpommern supports research into extracorporeal therapy systems
Kick-off for the Central European Advanced Therapy and Immunotherapy Centre (CREATIC)
Doctoral scholarship for leukemia cell research
Joint appointment with Martin Luther University Halle-Wittenberg
Virtual twin to improve treatment with cancer immunotherapies
EU project investigates links between land use change, biodiversity loss and zoonosis risk
EU project promotes access to ATMPs and its use in clinical practice
New approach to early cancer detection honored with Hugo Geiger Prize
Fraunhofer IZI expands expertise in the field of cellular immunotherapy with new branch office in Würzburg
Biomarkers for the successful treatment of tumors in the bone marrow identified
Fraunhofer Institute for Cell Therapy and Immunology wins an award in the Mecklenburg-Vorpommern competition for ideas for the healthcare industry
New agent for the treatment of chronic inflammatory bowel diseases
Stephan Fricke appointed adjunct professor at Dresden Technical University (TUD)
SaxoCell future cluster starts second funding phase
QualiBioPharma qualification program honored as cluster success of the year 2024
Non-viral vectors for CAR-T cell therapy
Fraunhofer IZI relies on certified energy management
Recognition for our animal care: Fraunhofer IZI co-hosts the German TechWeek
Fraunhofer IZI’s founding director honored for his dedication to the city of Leipzig
Rare side effect after immunotherapy against cancer
Scientific conference highlights AAV technologies
Can bioactive components of breast milk support the prevention of infectious diseases?
Fraunhofer Institute for Cell Therapy and Immunology in Leipzig celebrates its 20th anniversary
Media Library
Events
Publications
Jobs / career
[X]
Jobs / career
What makes us special
Career starters and professionals
Pupils and students
Doctoral program
Cooperative course
Vocational training
FAQ
Work environments
Contact
[X]
Contact
How to reach us in Leipzig
How to reach us in Potsdam-Golm
How to reach us in Halle (Saale)
How to reach us in Rostock
Research management
Business Development (Diagnostics / ZDD) and Patent Management
More
Where am I?
Homepage
Departments
Halle (Saale) location
Halle (Saale) location
© Fraunhofer IZI
Department of Drug Design and Target Validation
Active agents and structural biology
Analytics
Antibody technologies
Pharmacology
more info
Related Links:
Leipzig location
Rostock location
Würzburg location
Potsdam-Golm location
Fraunhofer Institute for Cell Therapy and Immunology IZI